Health Care & Life Sciences » Medical Equipment & Supplies | Immunodiagnostic Systems Holdings PLC

Immunodiagnostic Systems Holdings PLC | Balance Sheet

Fiscal year is April-March. All values GBP Thousands.
2014
2015
2016
2017
2018
2019
Cash & Short Term Investments
26,690.00
23,730.00
26,554.00
31,495.00
28,533.00
27,713
Total Accounts Receivable
7,968.00
8,211.00
9,117.00
9,877.00
11,442.00
12,005
Inventories
6,458.00
6,805.00
7,509.00
7,572.00
8,378.00
7,819
Other Current Assets
1,422.00
1,803.00
-
-
-
-
Total Current Assets
42,538.00
40,549.00
43,180.00
48,944.00
48,353.00
47,537
Net Property, Plant & Equipment
9,161.00
10,264.00
9,629.00
8,505.00
7,467.00
6,852
Long-Term Note Receivable
314.00
273.00
294.00
333.00
-
283
Intangible Assets
48,696.00
45,900.00
9,211.00
10,450.00
10,993.00
11,177
Other Assets
-
-
-
-
351.00
-
Total Assets
102,461.00
97,101.00
62,340.00
68,735.00
67,541.00
65,919
ST Debt & Current Portion LT Debt
-
362.00
89.00
77.00
80.00
Accounts Payable
1,901.00
2,076.00
1,458.00
1,845.00
2,093.00
Income Tax Payable
267.00
971.00
3.00
53.00
58.00
Other Current Liabilities
5,592.00
3,785.00
5,002.00
6,244.00
5,033.00
Total Current Liabilities
7,760.00
7,194.00
6,552.00
8,219.00
7,264.00
Long-Term Debt
-
1,238.00
1,220.00
1,252.00
1,201.00
Provision for Risks & Charges
850.00
1,135.00
1,419.00
1,611.00
1,108.00
Deferred Taxes
3,980.00
5,654.00
1,525.00
418.00
719.00
Total Liabilities
14,342.00
15,336.00
10,742.00
12,003.00
10,669.00
Common Equity (Total)
86,586.00
80,408.00
51,598.00
56,732.00
56,872.00
Total Shareholders' Equity
86,586.00
80,408.00
51,598.00
56,732.00
56,872.00
Total Equity
86,586.00
80,408.00
51,598.00
56,732.00
56,872.00
Liabilities & Shareholders' Equity
102,461.00
97,101.00
62,340.00
68,735.00
67,541.00
Non-Equity Reserves
1,533.00
1,357.00
-
-
-

About Immunodiagnostic Systems Holdings

View Profile
Address
Boldon Business Park
Boldon Tyne and Wear NE35 9PD
United Kingdom
Employees -
Website http://idsltd.com
Updated 07/08/2019
Immunodiagnostic Systems Holdings Plc engages in the development, manufacture, and marketing of in-vitro diagnostic tests (IVD) to the clinical laboratory market. It operates through the following business units: Automated IVD Business, Manual IVD Business, and Licensing and Technology. The Automated IVD Business unit offers an analyser which automates nearly all steps required for performing a test using their kits.